COMP <GO>
HRMY vs UNH // REVENUE GROWTH (YOY)
Harmony Biosciences Holdings Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: HRMY 9
— UNH 4
▲ REVENUE GROWTH (YOY) LEADER: HRMY
LAST: $38.59 (+0.23%) • MKT CAP: $2.25B
revenue-growth
21.50%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
revenue-growth
6.46%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HRMY VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HRMY | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.20% | 88.57% | -11.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 63.00% | 11.47% | +51.53 | HRMY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.8x | 16.4x | -8.65 | HRMY | /valuation <GO> |
| Free Cash Flow Yield | 15.48% | 6.48% | +9.00 | HRMY | /fcf-yield <GO> |
| Operating Margin | 24.00% | 4.82% | +19.18 | HRMY | /operating-margins <GO> |
| Net Profit Margin | 18.30% | 3.14% | +15.16 | HRMY | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 21.50% | 6.46% | +15.04 | HRMY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.38 | 3.12 | +2.26 | HRMY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | HRMY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.1 | 59.2 | -8.14 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.9x | 17.1x | -5.19 | HRMY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.25B | $368.83B | -$366.58B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HRMY REV | UNH REV | HRMY GROSS % | UNH GROSS % | HRMY FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $868.5M | $447.57B | 77.2% | 88.7% | $347.9M | $16.07B |
| FY 2024 | $714.7M | $400.28B | 78.1% | 88.3% | $218.7M | $20.70B |
| FY 2023 | $582.0M | $371.62B | — | 89.6% | $219.4M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HRMY // BETA —
UNH // BETA 0.33